Related Experiment Video

Updated: Jun 4, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Emerging Treatments and Novel Modalities in Head and Neck Cancers

Kedar Kirtane1, Harsh Dhar2, Anil D'Cruz3

  • 1Moffitt Cancer Center & Research Institute, Tampa, FL.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|June 2, 2026
PubMed

Insights

Head and neck cancer (HNC) continues to have high mortality and morbidity rates. Promising new treatments and global implementation strategies are emerging to improve patient outcomes.

Area of Science:

  • Oncology
  • Radiopharmaceuticals
  • Immunotherapy

Background:

  • Head and neck cancer (HNC) presents significant challenges with persistently high mortality and morbidity rates.
  • Existing treatment paradigms require advancement to effectively manage diverse HNC subtypes.

Purpose of the Study:

  • To review contemporary therapeutic innovations and implementation strategies for improving head and neck cancer outcomes.
  • To highlight the need for advancements that address global disparities in HNC care.

Main Methods:

  • Review of novel radiopharmaceuticals.
  • Analysis of injectable therapies and advanced systemic treatments, including immunomodulators and cell-based therapies.
  • Examination of system-level changes to address global health inequities.

Main Results:

  • Emerging therapeutic avenues show promise for improving HNC outcomes.
  • Implementation of these advances is crucial for maximizing clinical benefit across HNC subtypes.
  • Addressing global disparities is essential for equitable HNC management.

Conclusions:

  • Head and neck cancer remains a critical area for research and therapeutic innovation.
  • Novel treatments combined with strategic implementation are key to overcoming current challenges in HNC.
  • Future efforts must focus on both scientific advancement and global accessibility of care.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...